EF3A17BB-43EC-45D9-84C5-FBF8AB4B53EC_1_105_c

20 November, 2023

Home
Technology
Pipeline
About Us
News
Careers
Contact

Curemark is a late stage clinical biopharmaceutical company developing therapies for the treatment of serious neurodevelopmental and neurodegenerative disorders, with CM-AT as the lead asset. The company’s pipeline is built upon a proprietary enzyme replacement technology that biologically addresses the gut-brain pathway connection of many neurological diseases.

+1 (914) 824-9700

Privacy | Terms of Use